Navigation Links
CVS Caremark Donates Over $750,000 to The One Fund Boston
Date:5/14/2013

WOONSOCKET, R.I., May 14, 2013 /PRNewswire/ -- CVS Caremark announced today that a month-long, in-store fundraising campaign at CVS/pharmacy locations throughout Greater Boston raised over $650,000 in donations from customers to The One Fund Boston, which was established by Massachusetts Governor Deval Patrick and Boston Mayor Thomas Menino to raise money for victims and families who were affected by the attack on the Boston Marathon.

(Logo: http://photos.prnewswire.com/prnh/20090226/NE75914LOGO )

The in-store donation campaign at more than 260 Boston-area CVS/pharmacy stores ran from April 19 to May 11, during which customers could add $1, $3 or an amount of their choice to their purchase at the register. This fundraising follows a $100,000 donation to The One Fund Boston made by the CVS Caremark Charitable Trust, the private foundation of CVS Caremark.   

"We sincerely thank all of our Boston customers who supported our in-store campaign for The One Fund Boston and generously made a donation to help victims and families recover from this tragedy," said Larry Merlo , President and CEO of CVS Caremark. "I also want to thank our colleagues who responded quickly to launch this fundraising campaign within a few days of the Boston Marathon."

The One Fund Boston continues to accept online donations from the public at www.onefundboston.org.  

About the CVS Caremark Charitable Trust
The CVS Caremark Charitable Trust, Inc. is a private foundation created by CVS Caremark Corporation (NYSE: CVS). CVS Caremark is the largest pharmacy health care provider in the nation. The Trust's mission is to provide funding for health care, education and community involvement initiatives in CVS Caremark communities. General information about CVS Caremark is available through the Investor Relations portion of the Company's Web site at http://info.cvscaremark.com/investors or through the Web site's newsroom at http://info.cvscaremark.com/newsroom

About CVS/pharmacy
CVS/pharmacy, the retail division of CVS Caremark Corporation (NYSE: CVS), is America's leading retail pharmacy with more than 7,400 CVS/pharmacy and Longs Drug stores. CVS/pharmacy is reinventing pharmacy to help people on their path to better health by providing the most accessible and personalized expertise, both in its stores and online at CVS.com. General information about CVS/pharmacy and CVS Caremark is available at http://info.cvscaremark.com.

MEDIA CONTACT:
Mike DeAngelis
michael.deangelis@cvscaremark.com
401.770.2645 


'/>"/>
SOURCE CVS Caremark
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. CVS Caremark Reports Strong First Quarter Results
2. CVS Caremark Offers Advice on Proper Management, Storage and Disposal of Medications in Light of New Study on Teen Abuse of Prescription Drugs
3. Cardinal Health Will Continue To Supply Pharmaceuticals To CVS Caremark Corporation
4. CVS Caremark Industry-Leading Generic Dispensing Rate Reduces Client Traditional Drug Spend by 3.6 Percent for 2012
5. CVS Caremark Charitable Trust Supports Non-profits Nationwide with $2.6 Million in Funding
6. CVS Caremark Research Finds Medication Adherence Can Improve Outcomes and Reduce Costs for Patients with Coronary Artery Disease
7. CVS Caremark MinuteClinic President Discusses Primary Care Innovation at London Healthcare Conferences
8. CVS Caremark Emphasizes Commitment to Older Americans at Annual American Society on Aging Conference
9. Accordant Health Services, a CVS Caremark Company, Receives URAC Case Management Accreditation
10. CVS Caremark CEO Addresses Economic Club of Pittsburgh on Reinventing Pharmacy for Better Health
11. CVS Caremark Appoints New Chief Digital Officer to Lead Digital Innovation Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... Mar. 29, 2017 Research and Markets has ... 2017-2021" report to their offering. ... The global energy-based aesthetic devices market to ... The report, Global Energy-Based Aesthetic Devices Market 2017-2021, has ... industry experts. The report covers the market landscape and its growth ...
(Date:3/29/2017)... 2017 Avelas Biosciences, Inc., a clinical stage oncology-focused company ... announced that Carmine N. Stengone , president and chief executive ... & Company 16 th Annual Healthcare Conference on Wednesday, April ... Westin Grand Central Hotel in New York City ... ...
(Date:3/29/2017)... Research and Markets has announced the addition of the "Italy ... report to their offering. ... Proton Therapy Market in Italy will double by ... currently three proton therapy centers in Italy that ... Italy , the first patients were treated with proton beams in ...
Breaking Medicine Technology:
(Date:3/29/2017)... ... March 30, 2017 , ... CHARM CITY RUN WELCOMES MERCY ... announced that Mercy Medical Center will serve as the official title sponsor of the ... Sunday, June 25, 2017, thousands of women will walk or run the course around ...
(Date:3/29/2017)... ... March 30, 2017 , ... Sports Brand EXOUS Bodygear announced today a special ... $29.97; for the remaining days of March, the price will be only $19.97. The ... price of just $10 (regular retail price $19.97). , The special promotional prices are ...
(Date:3/29/2017)... ... 29, 2017 , ... The Wall Centre Dental team is ... from Burnaby, BC. Patients in need of experienced orthodontics, laser dentistry, porcelain veneers, ... esteemed team at Wall Centre Dental. Drs. Parviz Roshan, Siamak Tehrani, Milton Reskovich ...
(Date:3/29/2017)... Horeb, WI (PRWEB) , ... March 29, 2017 , ... ... patients on early orthodontic treatment and accepting new pediatric patients, with or without a ... help young patients have a better orthodontic outcome and experience. When patients receive early ...
(Date:3/29/2017)... ... 2017 , ... Altima Technologies, Inc., the maker of popular ... assets and audio-video devices has recently updated its Visio Stencils library with new ... download shapes and stencils from http://www.VisioStencils.com. , New devices were added ...
Breaking Medicine News(10 mins):